Literature DB >> 19840582

Is age really a non-modifiable cardiovascular risk factor?

William B Kannel, Ramachandran S Vasan.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19840582      PMCID： PMC3760670          DOI： 10.1016/j.amjcard.2009.06.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

1.  The lifetime risk of stroke: estimates from the Framingham Study.

Authors:  Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; Rhoda Au; William B Kannel; Philip A Wolf
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

2.  Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study.

Authors:  Anatoli I Yashin; Igor V Akushevich; Konstantin G Arbeev; Lucy Akushevich; Svetlana V Ukraintseva; Aliaksandr Kulminski
Journal:  Age (Dordr)       Date:  2006-12

Review 3.  Age as a modifiable risk factor for cardiovascular disease.

Authors:  Allan D Sniderman; Curt D Furberg
Journal:  Lancet       Date:  2008-03-05       Impact factor: 79.321

4.  Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants.

Authors:  Dellara F Terry; Michael J Pencina; Ramachandran S Vasan; Joanne M Murabito; Philip A Wolf; Margaret Kelly Hayes; Daniel Levy; Ralph B D'Agostino; Emelia J Benjamin
Journal:  J Am Geriatr Soc       Date:  2005-11       Impact factor: 5.562

5.  Midlife risk factors and healthy survival in men.

Authors:  Bradley J Willcox; Qimei He; Randi Chen; Katsuhiko Yano; Kamal H Masaki; John S Grove; Timothy A Donlon; D Craig Willcox; J David Curb
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

6.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

7.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

8.  Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.

Authors:  Donald M Lloyd-Jones; Eric P Leip; Martin G Larson; Ralph B D'Agostino; Alexa Beiser; Peter W F Wilson; Philip A Wolf; Daniel Levy
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

9.  Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study.

Authors:  R J Goldberg; M Larson; D Levy
Journal:  Arch Intern Med       Date:  1996-03-11
  9 in total
  10 in total

1.  Integrating health into cognitive aging: toward a preventive cognitive neuroscience of aging.

Authors:  Avron Spiro; Christopher B Brady
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

Review 2.  Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.

Authors:  José J Fuster; Kenneth Walsh
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

Review 3.  Age as a risk factor.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Med Clin North Am       Date:  2011-12-12       Impact factor: 5.456

4.  Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.

Authors:  Yuichiro Yano; Christopher J O'Donnell; Lewis Kuller; Maryam Kavousi; Raimund Erbel; Hongyan Ning; Ralph D'Agostino; Anne B Newman; Khurram Nasir; Albert Hofman; Nils Lehmann; Klodian Dhana; Ron Blankstein; Udo Hoffmann; Stefan Möhlenkamp; Joseph M Massaro; Amir-Abbas Mahabadi; Joao A C Lima; M Arfan Ikram; Karl-Heinz Jöckel; Oscar H Franco; Kiang Liu; Donald Lloyd-Jones; Philip Greenland
Journal:  JAMA Cardiol       Date:  2017-09-01       Impact factor: 14.676

Review 5.  Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease.

Authors:  Changhee Jung; Megan A Evans; Kenneth Walsh
Journal:  Curr Opin Cardiol       Date:  2020-05       Impact factor: 2.108

Review 6.  Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.

Authors:  Irene Maeve Rea; David S Gibson; Victoria McGilligan; Susan E McNerlan; H Denis Alexander; Owen A Ross
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 7.  Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.

Authors:  Isidoro Cobo; Tiffany Tanaka; Christopher K Glass; Calvin Yeang
Journal:  Curr Opin Hematol       Date:  2022-01-01       Impact factor: 3.284

8.  Somatic mutations in single human cardiomyocytes reveal age-associated DNA damage and widespread oxidative genotoxicity.

Authors:  Sangita Choudhury; August Yue Huang; Junho Kim; Zinan Zhou; Katherine Morillo; Eduardo A Maury; Jessica W Tsai; Michael B Miller; Michael A Lodato; Sarah Araten; Nazia Hilal; Eunjung Alice Lee; Ming Hui Chen; Christopher A Walsh
Journal:  Nat Aging       Date:  2022-08-11

9.  Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis.

Authors:  Stevan D Stojanović; Jan Fiedler; Johann Bauersachs; Thomas Thum; Daniel G Sedding
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

Review 10.  Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention.

Authors:  Xudong Zhu; Zhiyang Chen; Weiyan Shen; Gang Huang; John M Sedivy; Hu Wang; Zhenyu Ju
Journal:  Signal Transduct Target Ther       Date:  2021-06-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.